Reliable and precise lipoprotein detection based on a self-priming hairpin-triggered Cas12a/crRNA based signaling strategy
- 21 November 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (1) , 46-54
Abstract
Cardiovascular disease, intimately linked to dyslipidemia, is one of the leading global causes of mortality. Dyslipidaemia often presents as an elevated concentration of low-density lipoprotein (LDL) and a decreased concentration of high-density lipoprotein (HDL). Therefore, accurately measuring the levels of LDL and HDL particles is crucial for assessing the risk of developing cardiovascular diseases. However, conventional approaches can commonly quantify HDL/LDL particles by detecting cholesterol or protein molecules within them, which may fail to reflect the number of intact particles. In addition, these approaches are sometimes tedious and time-consuming, highlighting the need for a novel method for precise and effective identification of intact HDL and LDL particles. We have devised a technique that allows accurately and sensitively determining the levels of intact HDL and LDL in a sample without the need for isolation. This method relies on antibody-based immobilization and a self-priming hairpin-triggered Cas12a/crRNA signaling strategy. Based on the elegant design, this technique can be employed to directly and precisely measure the concentration of “actual” HDL and LDL particles, rather than the cholesterol content inside HDL and LDL. The approach has detection limits of 12.3 mg dL−1 and 5.4 mg dL−1 for HDL and LDL, respectively, and is also suitable for analyzing lipoproteins in clinical samples. Hence, this platform exhibits immense potential for clinical applications and health management.Keywords
Funding Information
- National Natural Science Foundation of China (82202645)
- Harbin Medical University (2021B01)
- Postdoctoral Foundation of Hei Long Jiang Province (LBH-Q21114)
This publication has 18 references indexed in Scilit:
- Lipoprotein(a): a genetically determined risk factor for Cardiovascular diseaseCritical Reviews in Clinical Laboratory Sciences, 2023
- Remnant lipoprotein particles and cardiovascular disease riskBest Practice & Research Clinical Endocrinology & Metabolism, 2022
- Clinical epigenomics for cardiovascular disease: Diagnostics and therapiesJournal of Molecular and Cellular Cardiology, 2021
- CRISPR-Cas12a enhanced rolling circle amplification method for ultrasensitive miRNA detectionMicrochemical Journal, 2020
- Allosteric Probe-Initiated Wash-Free Method for Sensitive Extracellular Vesicle Detection through Dual Cycle-Assisted CRISPR-Cas12aACS Sensors, 2020
- Rolling Circular Amplification (RCA)-Assisted CRISPR/Cas9 Cleavage (RACE) for Highly Specific Detection of Multiple Extracellular Vesicle MicroRNAsAnalytical Chemistry, 2019
- Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosisVascular Pharmacology, 2016
- Lipoprotein MetabolismAmerican Journal of Kidney Diseases, 1993
- Lipoprotein(a), atherosclerosis and thrombosisProgress in Lipid Research, 1991
- High-density lipoprotein turnoverAmerican Heart Journal, 1987